XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Total revenue $ 6,812,038 $ 34,218,209
Cost of revenue 4,184,949 5,481,093
Gross profit 2,627,089 28,737,116
Operating expenses    
Sales and marketing 6,860,815 7,344,628
General and administrative 14,279,441 14,262,963
Research and development 22,962,593 17,438,098
Depreciation and amortization 1,230,474 1,282,718
Goodwill impairment charges 15,388,546
Total operating expenses 45,333,323 55,716,953
Loss from operations (42,706,234) (26,979,837)
Other income, net    
Interest income 1,161,913 704,045
Realized gain on investments 2,243,059
Loss on disposition of assets (2,578) (138,117)
Gain on remeasurement of acquisition contingencies 1,092,581 7,899,644
Gain (loss) on equity method investment in joint venture 100,703 (332,969)
Total other income, net 4,595,678 8,132,603
Loss before income taxes (38,110,556) (18,847,234)
Income tax benefit (2,777,691) (4,608,985)
Net loss (35,332,865) (14,238,249)
Other comprehensive loss    
Change in net unrealized gains on marketable securities, net of tax (146,440) 293,140
Total other comprehensive income (loss) (146,440) 293,140
Comprehensive loss $ (35,479,305) $ (13,945,109)
Loss per common share:    
Basic $ (1.20) $ (0.45)
Diluted $ (1.20) $ (0.45)
Weighted average shares outstanding:    
Basic 29,346,599 31,479,028
Diluted 29,346,599 31,479,028
Product Revenue [Member]    
Total revenue $ 991,473 $ 34,218,209
Grant Revenue [Member]    
Total revenue $ 5,820,565